2022 Refresher - CNS

The session will review the current clinical management of the most common malignant and benign adult CNS tumors. This review will be followed by an overview of the current clinical practice in the treatment of brain metastases. We will review the evolving role of stereotactic radiosurgery and whole brain radiotherapy in combination with novel therapeutic agents in the treatment of brain metastases. We will discuss in depth the roles of surgery, radiotherapy, and chemotherapy in the management of each of these tumors.

Significant recent progress has been made in the management of CNS tumors, with an emphasis on new molecular prognostic and predictive biomarkers that allow for appropriate treatment selection. Recent updates of the 5th edition WHO Classification of CNS tumors in 2021 include new tumor types that will be summarized. The importance of neuroimaging in helping clinicians improve diagnosis, treatment and response assessment for CNS tumors will be emphasized. This session highlights the need for a multi-disciplinary treatment approach in the management of CNS tumors.

 

Target Audience

The activity is designed to meet the interests of radiation oncologists and radiation oncology residents, medical oncologists, surgeons, physicists, nurses, radiation therapists, patologists, radiation therapists and dosimetrists.

 

Learning Objectives

    Upon completion of this live activity, attendees should be able to do the following:

    • Discuss the role of each modality including surgery, radiotherapy, and chemotherapy in managing the major malignant and benign adult primary CNS tumors
    • Describe the new updates of the 5th edition of the WHO Classification of Tumors of the CNS 2021.  substantial heterogeneity that exists within these tumor types and understand the prognostic and predictive variables that allow for the selection of the appropriate therapy.
    • Discuss key imaging modalities and features to differentiate recurrent tumor and treatment effect.
    Course summary
    Available credit: 
    • 1.50 Certificate of Attendance
      This activity was designated for 1.50 AMA PRA Category 1 Credit™.
    • 1.50 SA-CME

      The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

      The American Society for Radiation Oncology (ASTRO) designates this for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

      This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.50 self-assessment credits.

    Course opens: 
    03/25/2022
    Course expires: 
    04/27/2022
    Cost:
    $0.00
    Rating: 
    0

    Christina Tsien, MD is employed by Johns Hopkins University and receives compensation from Varian, Merck, BlueEarth, Novocure and Tocagen.

    The person(s) above served as the developer(s) of this activity. Additionally, the Education and CME/MOC Committees had control over the content of this activity.

    All relevant relationships have been mitigated.

    Disclosure link: 
    Committee Disclosures

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

    ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification. 

    Available Credit

    • 1.50 Certificate of Attendance
      This activity was designated for 1.50 AMA PRA Category 1 Credit™.
    • 1.50 SA-CME

      The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

      The American Society for Radiation Oncology (ASTRO) designates this for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

      This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.50 self-assessment credits.

    Price

    Cost:
    $0.00
    Please login or register to take this course.

    Policies: 
        • No refunds, extensions or substitutions will be made for those registrants who, for any reason, were unable to attend or were tardy for the session.
        • No credits will be granted and no refunds, exchanges or transfers will be given to those who do not pass.
        • ASTRO staff cannot make modifications to your submitted materials.
     

    Required Hardware/software

    One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.